MVP study on cholesterol genetics could lead to new treatments for heart disease, diabetes

//MVP study on cholesterol genetics could lead to new treatments for heart disease, diabetes

MVP study on cholesterol genetics could lead to new treatments for heart disease, diabetes

A team led by VA and Stanford University School of Medicine researchers has identified three genetic mutations that govern cholesterol levels. The finding could lead to the development of new drugs to treat cardiovascular disease and diabetes.https://www.research.va.gov/currents/1018-MVP-study-on-cholesterol-genetics-could-lead-to-new-treatments-for-heart-disease-diabetes.cfm

2018-11-27T17:05:21+00:00November 27th, 2018|Categories: News|